NTLA
Intellia Therapeutics Inc
Price:  
14.72 
USD
Volume:  
1,567,771.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NTLA WACC - Weighted Average Cost of Capital

The WACC of Intellia Therapeutics Inc (NTLA) is 6.9%.

The Cost of Equity of Intellia Therapeutics Inc (NTLA) is 10.10%.
The Cost of Debt of Intellia Therapeutics Inc (NTLA) is 5.00%.

Range Selected
Cost of equity 8.10% - 12.10% 10.10%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.9% - 7.9% 6.9%
WACC

NTLA WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.91 1.29
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.10% 12.10%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 5.9% 7.9%
Selected WACC 6.9%